2024
|
Invention
|
Sulfoximine glycosidase inhibitors.
Compounds of formula (I)
Compounds of formula (I)
Co... |
2022
|
Invention
|
Acid addition salts of piperazine derivatives. The invention relates to acid addition salts of pi... |
2021
|
Invention
|
Sulfoximine glycosidase inhibitors. Compounds of formula (I), wherein A, R, W, Q, n, and m have t... |
|
Invention
|
Medicaments comprising glycosidase inhibitors.
The present invention relates to pharmaceutical c... |
|
Invention
|
Glycosidase inhibitors. The disclosure relates to compounds of formula (I) useful in the treatmen... |
2020
|
Invention
|
Fused glycosidase inhibitors.
This application pertains to compounds of formula (I)
This appli... |
2019
|
Invention
|
Tetrahydro-benzoazepine glycosidase inhibitors. 4, L, W, Z, R′″, m and n have the meaning accordi... |
|
Invention
|
Pyrrolidine glycosidase inhibitors.
3b, Z and p have the meaning according to the claims, can... |
|
Invention
|
Spiro compounds as glycosidase inhibitors. 2 and n have the meaning according to the claims, can ... |
|
Invention
|
Succinate and fumarate acid addition salts of piperazine derivatives. The invention relates to su... |
2017
|
Invention
|
Linear glycosidase inhibitors. Compounds of formula (I), wherein A, R, W, Q, L, n and m have the ... |
|
Invention
|
Annulated glycosidase inhibitors. x and u have the meaning according to the claims, can be employ... |
|
Invention
|
Substituted dihydrobenzofuran glycosidase inhibitors. Compounds of formula (I), wherein R′, R″, R... |
|
Invention
|
Glycosidase inhibitors. Compounds of formula (I), wherein A, R, W, Q, n and m have the meaning ac... |
|
Invention
|
Glycosidase inhibitors. Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning acc... |
2014
|
Invention
|
Tetraaza-cyclopenta[a]indenyl derivatives. The present invention provides compounds of Formula (I... |